glp-1 receptor agonists and sglt2 inhibitors Complementary Yet Distinct Roles of in Cardiovascular Risk Reduction GLP-1 receptor agonists and SGLT2

Leave-one-out sensitivity analyses confirmed the direction and magnitude of the AUD finding but highlighted the limited evidence base for hospitalization

GLP-1 receptor agonists trace their roots back to exendin-4, a peptide isolated from Gila monster venom in the early 1990san insight that eventually led to exenatide and reshaped the treatment of diabetes and metabolic disease

95% CI, -0.02 to 0.03

The success of these agents in preclinical models and clinical trials suggests a promising future for multiagonists in the treatment of metabolic diseases, with the most recent glucose-dependent insulinotropic peptide receptor:glucagon-like peptide 1 receptor:glucagon receptor (GIPR:GLP-1R:GCGR) triagonists rivaling the efficacy of bariatric surgery

ContinuEM provides safe, doctor-supervised GLP-1 weight loss solutions in Long Beach, Lakewood, and greater LA.

Learn what patients and prescribers should know about lean mass, protein, and exercise.